Join to access to all OVN content. Join for Free

Results for 'trials'

Find oncology podcasts about trials — interviews, panel discussions, and expert-led audio on cancer innovation. Open any episode for listening options and show notes; switch tabs to explore articles, partners, and community members.

How and Why Medical Affairs Can Support Diversity in Clinical Trials
Partner Avatar MSL Talk: Tom Caravela, Brad Atkinson, Brian Wilson, Christina Wright
How and Why Medical Affairs Can Support Diversity in Clinical Trials

diversity in clinical trials, role of MSLs, FDA guidance on diversity, patient-centric approaches, cultural awareness and allyship

In this episode, Tom Caravela is joined by Brad Atkinson, Brian Wilson, and Christina Wright to explore the critical role of diversity in clinical trials and the MSL’s part in fostering inclusivity. The discussion covers FDA guidance on diversity, challenges in therapeutic areas, and the …

Aug 24th • 42 mins listen

Exploring the MSL role in IITs (Investigator Initiated Trials)
Partner Avatar MSL Talk: Tom Caravela, Gail Rosen Spahn
Exploring the MSL role in IITs (Investigator Initiated Trials)

Investigator-Initiated Trials, MSL engagement, KOL engagement, IIT programs, Medical Affairs

In this episode, Gail Rosen Spahn joins to delve into Investigator-Initiated Trials (IITs) and their significance in the MSL landscape. The discussion covers the definition and understanding of IIT programs, the responsibilities of MSLs and investigators, and the role of sales reps. The convers…

Oct 4th • 33 mins listen

Evolving Role of MSL Field Support for Clinical Trials
Partner Avatar MSL Talk: Tom Caravela, Khalil Ahmed
Evolving Role of MSL Field Support for Clinical Trials

Medical Science Liaisons, clinical trials, MSL involvement, Syneos Health, Khalil Ahmed

In this episode, Tom Caravela is joined by Khalil Ahmed to explore the integral role of Medical Science Liaisons (MSLs) in clinical trials. Khalil shares his background and discusses the significant impact MSLs have on site selection, recruitment, and training. The conversation delves into the …

Apr 4th • 34 mins listen

IO Clinical Trials During COVID-19
OVN Avatar Cancer Buzz Podcast
IO Clinical Trials During COVID-19

On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …

Jun 23rd • 13 mins listen

The Role of the Clinical Trials Navigator
OVN Avatar Cancer Buzz Podcast
The Role of the Clinical Trials Navigator

Adding a clinical trials navigator to this practice team required a business case that demonstrated return on investment. After a successful onboarding, this navigator is now the point person to help identify patients appropriate for clinical trials and to help busy clinicians with enrollment crit…

Aug 29th • 6 mins listen

How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?
OVN Avatar ournal of Clinical Oncology (JCO) Podcast
How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?

This podcast considers the impact of exclusion criteria on clinical trials, generalizability, and the complexity of modernizing eligibility while maintaining trial integrity.

Mar 25th • 10 mins listen

 ctDNA in DLBCL: A Blueprint for Better Clinical Trials?
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
ctDNA in DLBCL: A Blueprint for Better Clinical Trials?

Current clinical characteristics and demographics are not sufficient to capture aggressive disease in clinical trials of newly diagnosed DLBCL. Novel tools, such as measurement of tumor burden via ctDNA, are needed. By : Dr. Matthew Maurer.

Apr 10th • 7 mins listen

Improving Transparency in Phase 1 Clinical Trials
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
Improving Transparency in Phase 1 Clinical Trials

Dr. Shannon Westin and her guests, Dr. Paul Frankel, Dr. Judith Karp, and Dr. Robert Maki discuss how to better inform patients of the risks involved in phase 1 clinical trials.

Feb 9th • 29 mins listen

How AI Can Improve Patient Identification and Recruitment for Clinical Trials
OVN Avatar Asco Daily News Podcast
How AI Can Improve Patient Identification and Recruitment for Clinical Trials

On today's episode, we will be discussing the promise of artificial intelligence to improve patient recruitment in clinical trials and advanced clinical research. Joining me for this discussion is Dr. Arturo Loaiza-Bonilla, the medical director of oncology research at Capital Health in Philad…

Aug 15th • 19 mins listen

The Practical Side of Clinical Trials
OVN Avatar The Oncology Nursing Podcast
The Practical Side of Clinical Trials

ONS member Teresa Knoop, MSN, RN, AOCN®, assistant director of clinical trials at Vanderbilt Ingram Cancer Center in Nashville, TN, joins ONS’s Barbara Lubejko, MS, RN, to discuss the practical side of clinical trials for oncology nursing, including addressing long-term side effects, han…

Sep 18th • 39 mins listen

Oncology Clinical Trials and Drug Development
OVN Avatar The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development

ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…

Oct 16th • 38 mins listen

Diversity in Cancer Clinical Trials
OVN Avatar The Oncology Nursing Podcast
Diversity in Cancer Clinical Trials

“I think it’s important to ensure that you consider each person uniquely. Because no matter how much I know or the nurse knows about the population, everybody is a little bit different. It’s really important to personalize every approach and ask them what they know and meet them …

May 29th • 27 mins listen

More Moments, More Memories: A Family’s Legacy in Oncology
OVN Avatar Kirk Shepard
More Moments, More Memories: A Family’s Legacy in Oncology

family, legacy, oncology

The Shaw sisters reveal how teamwork, advocacy, and patient focus can transform cancer care—inside and outside the pharma world.

Apr 28th • 0 min listen

What it Takes to Close the Gap in Pediatric Cancer Care with Leo Wang, M.D., Ph.D.
Partner Avatar Monty Pal
What it Takes to Close the Gap in Pediatric Cancer Care with Leo Wang, M.D., Ph.D.

City of Hope, Academic Clinical Research, CAR T‑cell therapy gene therapy

In this episode, Leo Wang, M.D., Ph.D., pediatric oncologist, Clinical Director of the Gene Therapy Program and Director of the City of Hope Alpha Clinic, discusses the realities of caring for children with cancers that still have few effective treatments. He reflects on what it takes to begin chang…

Apr 21st • 46 mins listen

Breakthroughs in Oncology Drug Development with Dr. Roy Baynes
OVN Avatar Kirk Shepard
Breakthroughs in Oncology Drug Development with Dr. Roy Baynes

How do world-changing cancer treatments go from concept to reality? Tune in and discover how strategy, leadership, and heart unite to change lives in oncology—listen now.

Mar 31st • 28 mins listen

Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
Partner Avatar Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray

City of Hope, Academic Research, precision medicine, AI

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…

Feb 23rd • 43 mins listen

Humanizing Cancer Treatment Through Whole-Person Care
Partner Avatar Monty Pal
Humanizing Cancer Treatment Through Whole-Person Care

City of Hope, Academic Research, palliative care, quality of life, pain management

Dr. Betty Ferrell on her global legacy in palliative care and why whole-person treatment is as crucial as fighting cancer itself.

Apr 21st • 47 mins listen

How a Bold Yes Became a Scientific Breakthrough
Partner Avatar Monty Pal
How a Bold Yes Became a Scientific Breakthrough

City of Hope, Academic Research

Dr. Linda Malkas shares the story behind AOH1996—how one bold “yes” led to a new cancer drug and a legacy built from love and science.

Jun 9th • 47 mins listen

Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
Partner Avatar Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery

City of Hope, Academic Research, ASCO, precision, AI, dose strategy

Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.

Jun 23rd • 43 mins listen

Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
Partner Avatar Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy

diagnostic, breast cancer, digital, biomarker, genetic testing, advocacy

Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.

Oct 19th • 26 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...